Target
An anatomically identifiable hypercontracture, paravertebral region or periosteal pain.
FROriginal method developed in Geneva
A developing method using sterile single-use needles for selected anatomical and neurosegmental targets—distinct from traditional acupuncture.
Rue de Fribourg 7 · 1201 Geneva

Segmentopuncture targets selected deep hypercontractures, paravertebral regions or periosteal pain identified during examination. Controlled electrical stimulation may be used when indicated.
The procedure is preceded by neurosegmental formulation, anatomical localisation, contraindication screening and informed consent. It is followed by reassessment and, when relevant, manual or active rehabilitation.
The method is being developed and documented by Gerry Ivanov in Geneva. It is not a universal treatment and its overall framework requires continuing clinical and scientific evaluation.

02 · IMG CLINICAL REASONING
Pain alone is not enough to justify an invasive technique.
An anatomically identifiable hypercontracture, paravertebral region or periosteal pain.
A plausible relationship to the neurosegment, symptoms and functional tests.
Coagulation, anticoagulants, infection, pregnancy, fragility, implants and other precautions.
Explanation of alternatives, possible sensations, reactions and limitations.
03 · CLINICAL PATHWAY
Asepsis, progressive dosing and monitoring structure the procedure.
Examination, indication, contraindications and consent.
Anatomical targeting, sterile needle and controlled stimulation if indicated.
Reassess pain, mobility and tolerance.
Connect the method to relevant rehabilitation rather than isolate it.
04 · INDICATIONS
05 · FAQ
No. Its reasoning, targets and clinical integration are distinct from traditional acupuncture.
No. It is considered only when a specific indication is identified and accepted.
Yes. Sterile single-use needles and an aseptic procedure are used.
Its components draw on anatomy and neurophysiology, while the overall method is in development and requires continued specific evaluation.
Your next step
Contact IMG Clinic directly or complete the Clinical Pathway Engine™ beta to prepare an initial clinician-reviewed pathway.